Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 2003-2011
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.2003
Table 1 Univariate analysis of the patients with different prognoses
Factor
Classify
Survival (n = 50)
Death (n = 10)
χ2
P value
SexMale34 (68.00)6 (60.00)0.2400.624
Female16 (32.00)4 (40.00)
Age> 60 yr21 (42.00)7 (70.00)2.6250.105
Admidia 60 yr29 (58.00)3 (30.00)
Bommann classificationI-II mold35 (70.00)4 (40.00)3.2970.069
III-IV mold15 (30.00)6 (60.00)
Histological typePoorly differentiated30 (60.00)1 (10.00)10.1410.006
Moderately differentiated11 (22.00)3 (30.00)
Well-differentiated9 (18.00)6 (60.00)
Tumor size≤ 5 cm38 (76.00)2 (20.00)11.760< 0.001
> 5 cm12 (24.00)8 (80.00)
TNM by stagesI-II designated time35 (70.00)1 (10.00)12.500< 0.001
III-IV designated time15 (30.00)9 (90.00)
Vascular invasionHave13 (26.00)6 (60.00)4.4520.035
Not have37 (74.00)4 (40.00)
Postoperative adjuvant chemoradiation therapyNot have16 (32.00)8 (80.00)8.0000.005
Have34 (68)2 (20)
Lymphatic metastasisHave10 (20)3 (30)0.4910.483
Not have40 (80)7 (70)
Table 2 Assignment of the regression analysis
Factor
Factor pattern
The assignment situation
PatientClassified variable1: Survival, 2: Death
Histological typeClassified variable1: Poorly differentiated, 2: Moderately differentiated, 3: Highly differentiated
Tumor sizeClassified variable1: ≤ 5 cm, 2: > 5 cm
TNM by stagesClassified variable1: I period, 2: About period
Vascular invasionClassified variable1: Yes, 2: None
Postoperative adjuvant chemoradiation therapyClassified variable1: None, 2: To have
Table 3 Factors influencing the patient outcomes
FactorBSEWaldFree degreeConspicuousnessExp (B)A 95.0%CI of exp (B)
Lower limit
Superior limit
Histological type0.1790.1920.86210.3531.1960.821.743
Tumor size0.1190.3460.11810.7321.1260.5712.221
TNM by stages0.6180.3353.40410.0651.8550.9623.574
Vascular invasion0.1330.3480.14610.7021.1420.5782.26
Postoperative adjuvant chemoradiation therapy0.7020.3553.91310.0482.0181.0064.046